A drug used alone or with other drugs to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, Waldenstrom macroglobulinemia (a type of non-Hodgkin lymphoma), mantle cell lymphoma, or marginal zone lymphoma. It is also being studied in the treatment of other types of cancer. Ibrutinib blocks a protein called BTK, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called Imbruvica. US Brand Name(s)Imbruvica
FDA ApprovedYes
Are you looking for or in search of FDA approved “ibrutinib tablets, for oral use in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for Leukemia treatment. Need Access of “ibrutinib tablets, for oral use, get in touch with our healthcare professional.
Ibrutinib, sold under the brand name Imbruvica among others, is a small molecule drug that inhibits B-cell proliferation and survival by irreversibly binding the protein Bruton’s tyrosine kinase (BTK). Blocking BTK inhibits the B-cell receptor pathway, which is often aberrantly active in B cell cancers. Ibrutinib is therefore used to treat such cancers, including mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström’s macroglobulinemia.[
Ibrutinib is approved to treat:
- Chronic lymphocytic leukemia and small lymphocytic lymphoma in adults. It is used alone or with other drugs.
- Mantle cell lymphoma in adults who have received at least one other treatment.
- Marginal zone lymphoma. It is used in adults who have received at least one other CD20-targeted therapy.
- Waldenström macroglobulinemia (a type of non-Hodgkin lymphoma) in adults.
Ibrutinib is also being studied in the treatment of other types of cancer.
ibrutinib tablets, for oral use
Contact No.
Call us
+91 11 4350 7259
Emergency Contact
+91 93139 48015
Address
Visit us anytime
F-90/1 , Okhla Industrial Area,
Phase -1 , New Delhi. India
Send us an email
medicanthealthcare@outlook.com
info@medicanthealthcare.com